Arena Pharmaceuticals Competitors and Similar CompaniesClear all
Arena Pharmaceuticals's competitors and similar companies include UCB.
 Arena Pharmaceuticals Arena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing drugs that target G protein-coupled receptors (GPCRs). |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |
Founding Date | Founding Date 1997 | Founding Date 1928 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ Zug, CH Boston, US Park City, US | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 11522% decrease | Employees 9,052 |
Financial | ||
Revenue (est.) | Revenue (est.) $54k (FY, 2021) | Revenue (est.) €7.4b (FY, 2025) |
Net income | Net income ($616.4m) (FY, 2021) | Net income €1.6b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company